Cold Lasers in Action: Laser Hair Loss Treatment

A beautiful hair often produces the words competent, healthy, and attractive.

With hair loss, these words rarely fit. Hair loss is often the source of much insecurity for many of us. The major problem about hair loss is that while it is not deadly, it degrades the quality of life.

Baldness keeps a person from going out and enjoying the good things in life with friends, families, and especially with a potential mate. Certainly, only those that suffer from it will fully understand the essence of a good image in order to fit in.

The loss of hair can be reversed successfully without the need for drugs or surgeries. Low Level Laser Therapy is now widely practiced as a hair restoration technique in Europe and the U.S.A. Laser hair loss treatment is chemical-free, non-invasive, and does not cause any side effects.

LLLT is the application of low energy lasers—which have been known for positive benefits on the living cells—on the areas of baldness to stimulate hair growth through photobiostimulation and vasodilation. Low-level lasers only render up to 100 watts, which is why they cannot burn or cut.

By photobiostimulation, the cell’s available energy increases, thus increasing cellular production. During hair loss, the hair follicle cells are mostly in a dormant state. Low level lasers wake up these follicle cells to stimulate hair growth.

Through vasodilation, on the other hand, the food and oxygen supply of the hair follicles increases as the small blood vessels expand, allowing better blood circulation.

Unfortunately, LLLT doesn’t work on all types of alopecia. Laser hair loss treatment is mostly recommend for mild to moderate cases of androgenetic alopecia or pattern baldness, wherein the follicles are still in a dormant, not dead, state.

Hair loss due to viral or bacterial infections such as cicatricial alopecia cannot be treated with LLLT. There is evidence to suggest that laser hair loss treatment may be effective in addressing the problem of alopecia areata, a condition believed to be autoimmune. However, there is no conclusive study to spur a wide-scale treatment of AA through LLLT.